EUVIMEDSkopri EUVIMED
EditorialKommentar

Editorial: safety of topical steroids designed specifically for eosinophilic oesophagitis–new data bring new questions

Pierfrancesco Visaggi iD, Edoardo Vincenzo Savarino iD

Alimentary Pharmacology & Therapeutics · 2023

DOI: 10.1111/apt.17442 ↗

At a glance

Editorial in Alimentary Pharmacology & Therapeutics, 2023. Written by Pierfrancesco Visaggi and 1 co-authors. Institution: Gastroenterology Unit, Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Pisa, Italy. Major MEDLINE topics: Eosinophilic Esophagitis. Cited 4 times so far (Crossref); 10 references.

AstrattSubjectsDettalji biblijografiċiCiteRelated studies

Abstract (original language)

LINKED CONTENT This article is linked to Hirano et al papers. To view these articles, visit https://doi.org/10.1111/apt.17430 and https://doi.org/10.1111/apt.17476

Subjects

MeSH terms (MEDLINE)

Eosinophilic EsophagitisSteroidsGastritisHumansEosinophiliaEnteritis

Substances

Steroids

Authors and institutions

  • Gastroenterology Unit, Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Pisa, Italy.
  • Gastroenterology Unit, Department of Surgery, Oncology and Gastroenterology, University of Padua, Padua, Italy.
  • Gastroenterology Unit, Azienda Ospedale Università di Padova, Padua, Italy.

ORCID profiles: Pierfrancesco Visaggi, Edoardo Vincenzo Savarino

Cite

APA

Visaggi, P., & Savarino, E. V. (2023). Editorial: safety of topical steroids designed specifically for eosinophilic oesophagitis–new data bring new questions. Alimentary Pharmacology & Therapeutics. https://doi.org/10.1111/apt.17442

Vancouver

Visaggi P, Savarino EV. Editorial: safety of topical steroids designed specifically for eosinophilic oesophagitis–new data bring new questions. Alimentary Pharmacology & Therapeutics. 2023. doi:10.1111/apt.17442

BibTeX
@article{Visaggi2023,
  author = {Visaggi, Pierfrancesco and Savarino, Edoardo Vincenzo},
  title = {Editorial: safety of topical steroids designed specifically for eosinophilic oesophagitis–new data bring new questions},
  journal = {Alimentary Pharmacology & Therapeutics},
  year = {2023},
  doi = {10.1111/apt.17442}
}
Start for free →